Approval · Notice of Compliance 16028 · 2014
NEXHA: Notice of Compliance 16028
Issued September 4, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16028
- Date
- September 4, 2014
- Company
- Vetoquinol N A IncLavaltrie, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number (din) holder
- Therapeutic class
- Anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXHA | 02375176 | Marketed |
Medicinal ingredients
- HYALURONATE SODIUM 10 MG per ML